MedTrace Logo

Determination of the in Vitro Effects of Cationic Airway Lining Modulators (CALM) on Chronic Obstructive Pulmonary Disease (COPD) Sputum

NCT01096173 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2011-04-11

No results posted yet for this study

Summary

This study is intended to be an evaluation of the properties of human sputum collected from patients with COPD. It is hypothesized that cationic airway lining modulators will have beneficial effects on the rheological properties of sputum derived from patients with COPD. Approximately 10 patients with COPD will collect sputum at home for 5 days. Samples will be collected and tested in laboratory tests.

Conditions

Sponsors & Collaborators

  • The VA Western New York Healthcare System

    collaborator FED

  • Buffalo Institute For Medical Research

    collaborator UNKNOWN

  • Pulmatrix Inc.

    lead INDUSTRY

Principal Investigators

  • Sanjay Sethi, MD · Va Western NY Healthcare, Buffalo Institute for Medical Research

Eligibility

Min Age
35 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-06-30
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01096173 on ClinicalTrials.gov